Rituxan and Epilepsy - a phase IV clinical study of FDA data

Summary:

Epilepsy is reported as a side effect among people who take Rituxan (rituximab), especially for people who are female, 40-49 old, have been taking the drug for 1 - 6 months also take Folic Acid, and have Psoriatic arthropathy.

The phase IV clinical study analyzes which people have Epilepsy when taking Rituxan. It is created by eHealthMe based on reports of 64,282 people who have side effects when taking Rituxan from the FDA, and is updated regularly.

What is Rituxan?

Rituxan has active ingredients of rituximab. It is often used in rheumatoid arthritis. eHealthMe is studying from 64,791 Rituxan users. Check the latest studies of Rituxan.

What is Epilepsy?

Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures) is found to be associated with 1,163 drugs and 1,776 conditions by eHealthMe. Check the latest studies of Epilepsy.

On Jul, 07, 2026

64,282 people reported to have side effects when taking Rituxan.
Among them, 52 people (0.08%) have Epilepsy.

Among these 52 people:

How long have people been on Rituxan when they have Epilepsy? *

What is the gender of people who have Epilepsy when taking Rituxan? *

female: 77.78 %
male: 22.22 %

What is the age of people who have Epilepsy when taking Rituxan? *

What are other drugs people take besides Rituxan? *

Acetaminophen: 28 people, 53.85%
Actemra: 28 people, 53.85%
Folic Acid: 28 people, 53.85%
Simponi: 27 people, 51.92%
Plaquenil: 27 people, 51.92%
Arava: 26 people, 50.00%
Cetirizine Hydrochloride: 26 people, 50.00%
Cimzia: 26 people, 50.00%
Desoximetasone: 26 people, 50.00%
Enbrel: 26 people, 50.00%

What are other side effects people have besides Epilepsy? *

High Blood Cholesterol: 32 people, 61.54%
Drug Ineffective: 32 people, 61.54%
High Blood Pressure: 32 people, 61.54%
Nasopharyngitis (inflammation of the nasopharynx): 30 people, 57.69%
Joint Pain: 30 people, 57.69%
Confusional State: 29 people, 55.77%
Dizziness: 29 people, 55.77%
Weakness: 29 people, 55.77%
Diarrhea: 28 people, 53.85%
Headache (pain in head): 28 people, 53.85%

What are the existing conditions these people have? *

Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 22 people, 42.31%
Psoriasis (immune-mediated disease that affects the skin): 16 people, 30.77%
Migraine (headache): 16 people, 30.77%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 8 people, 15.38%
Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 6 people, 11.54%
Glioblastoma (most common and most aggressive malignant primary brain tumour in humans): 6 people, 11.54%
Stress And Anxiety: 5 people, 9.62%
Synovitis (inflammation of the synovial membrane): 4 people, 7.69%
Pemphigus (any of several acute or chronic skin diseases characterized by groups of itching blisters): 4 people, 7.69%
Pain: 4 people, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Rituxan and have Epilepsy?

- Check whether Epilepsy is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Rituxan:

Rituxan (64,791 reports)

Epilepsy treatments and more:

Epilepsy (129,285 reports)

Browse all side effects of Rituxan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Epilepsy:

Epilepsy (1,163 drugs)

Browse all the conditions that are associated with Epilepsy:

Epilepsy (1,776 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on rituximab (the active ingredients of Rituxan) and Rituxan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.